ProShares Ultra Nasdaq Biotechnology (NASDAQ:BIB – Get Free Report) was the recipient of a large drop in short interest during the month of December. As of December 15th, there was short interest totalling 3,900 shares, a drop of 7.1% from the November 30th total of 4,200 shares. Based on an average daily volume of 12,300 shares, the days-to-cover ratio is presently 0.3 days.
ProShares Ultra Nasdaq Biotechnology Stock Up 0.7 %
Shares of ProShares Ultra Nasdaq Biotechnology stock traded up $0.35 on Tuesday, reaching $50.58. 5,715 shares of the company traded hands, compared to its average volume of 22,065. The company has a 50 day moving average of $58.14 and a 200 day moving average of $61.69. ProShares Ultra Nasdaq Biotechnology has a 52 week low of $47.19 and a 52 week high of $69.56.
ProShares Ultra Nasdaq Biotechnology Increases Dividend
The firm also recently declared a dividend, which will be paid on Tuesday, December 31st. Stockholders of record on Monday, December 23rd will be given a $0.3964 dividend. The ex-dividend date of this dividend is Monday, December 23rd. This is a positive change from ProShares Ultra Nasdaq Biotechnology’s previous dividend of $0.15.
Institutional Inflows and Outflows
ProShares Ultra Nasdaq Biotechnology Company Profile
ProShares Ultra Nasdaq Biotechnology (the Fund) seeks daily investment results, before fees and expenses, that correspond to twice (200%) the daily performance of the Index. The return of the Fund for a period longer than a single trading day will be the result of each day’s returns compounded over the period, which will very likely differ from the inverse of the return of the Dow Jones United States Basic Materials Index (the Index) for that period.
Featured Stories
- Five stocks we like better than ProShares Ultra Nasdaq Biotechnology
- How to Find Undervalued Stocks
- 3 Stocks Helping to Bring AI to Healthcare
- Are Penny Stocks a Good Fit for Your Portfolio?
- 3 Stocks Ringing in The New Year With Large Buyback Announcements
- Transportation Stocks Investing
- Why 2024 Was Great for Stocks—and Why 2025 Could Be Even Better
Receive News & Ratings for ProShares Ultra Nasdaq Biotechnology Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ProShares Ultra Nasdaq Biotechnology and related companies with MarketBeat.com's FREE daily email newsletter.